These findings suggest that ADAM12 mediates the shedding of the ectodomain of pro-HB-EGF in SIP, which then binds to EGFR and activates it, thereby establishing a signaling pathway that contributes to SIP tumor growth. Here, ADAM12 is linked to neoplasm.